Cleared Traditional

K221852 - Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave L6 Peripheral IVL Catheter (FDA 510(k) Clearance)

Aug 2022
Decision
50d
Days
Class 2
Risk

K221852 is an FDA 510(k) clearance for the Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave L6 Peripheral IVL Catheter. This device is classified as a Percutaneous Catheter, Ultrasound (Class II - Special Controls, product code PPN).

Submitted by Shockwave Medical, Inc. (Santa Clara, US). The FDA issued a Cleared decision on August 16, 2022, 50 days after receiving the submission on June 27, 2022.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1250. Intended For Ultrasound Wave Enhanced Balloon Dilatation Of Lesions, Including Calcified Lesions, In The Peripheral Vasculature..

Submission Details

510(k) Number K221852 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 27, 2022
Decision Date August 16, 2022
Days to Decision 50 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code PPN - Percutaneous Catheter, Ultrasound
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1250
Definition Intended For Ultrasound Wave Enhanced Balloon Dilatation Of Lesions, Including Calcified Lesions, In The Peripheral Vasculature.